Public Pancreatic Cancer Reception Slated for Nov. 28
CINCINNATIIn honor of National Pancreatic Cancer Awareness Month, the University of Cincinnati (UC) Cancer Institute is hosting a reception and pancreatic cancer information fair on Wednesday, Nov. 28, 2012.
The Give Hope/Bethany Sininger Flege Pancreatic Cancer Research and Awareness Fund and BSI Engineering will present a $30,000 donation to the UC Cancer Institute in support of pancreatic cancer research at the reception.
Free and open to the public, the event will take place at the UC Health Barrett Center, 234 Goodman St., from 6 to 8 p.m. in the second-floor lobby.
Guests will hear from physician speakers and pancreatic cancer survivors as well as have access to materials highlighting pancreatic cancer risk factors, treatment options and community resources. Informational sessions include:
-
Screening for Pancreatic Cancer in High Risk Patients (6:40 p.m.)
Presented by Nathan Schmulewitz, MD, UC Health gastroenterologist and UC College of Medicine associate professor
-
Pancreatic Cancer Clinical Trials at the UC Cancer Institute (6:50 p.m.)
Presented by Olugbenga Olowokure, MD, UC Health medical oncologist and UC College of Medicine assistant professor
-
Pancreatic Cancer Patient Testimonials (7 p.m.)
A local man and woman share their personal stories about pancreatic cancer and treatment experience at the UC Health Barrett Center with the multidisciplinary UC Cancer Institute pancreatic cancer team
-
GIVE HOPE/BSI Engineering Check Presentation (7:40 p.m.)
Two local, private organizations present a donation for pancreatic cancer research at the UC Cancer Institute
Raffles and refreshments are also available. Guests are encouraged to wear purple to show their support in the fight against pancreatic cancer.
The Barrett Center is the adult outpatient care facility of the University of Cincinnati Cancer Institute, one of four UC and UC Health centers of excellence. The UC Cancer Institute Gastrointestinal Cancer Program offers patients the combined benefit of advanced, science-driven medicine with a personalized, compassionate approach to treatment and follow-up care.
The teammade up of radiation oncologists, radiologists, medical oncologists, pathologists, fellowship-trained surgical oncologists and a highly experienced oncology nursing staffmeets regularly to discuss and determine the best treatment plan for women affected by pancreatic cancer. To learn more about the team, visit uccancer.com.
The UC Cancer Institute is part of the Cincinnati Cancer Center, a partnership of the UC College of Medicine, Cincinnati Childrens Hospital Medical Center and UC Health. By leveraging the individual cancer strengths of each institution, the CCC has a mission of advancing care faster, especially for those with complex disease.
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.